Alpha Wave Global’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Alpha Wave Global’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-532,570	Closed	-$5.38M	–	76
2022 Q4	$5.38M	Hold	532,570	–	–	0.98%	32
2022 Q3	$5.29M	Hold	532,570	–	–	0.62%	52
2022 Q2	$5.27M	Buy	532,570 +67,150	+14%	+$658K	0.54%	57
2022 Q1	$4.58M	Hold	465,420	–	–	0.41%	61
2021 Q4	$4.58M	Buy	+465,420	New	+$4.57M	0.51%	53

Alpha Wave Global's BIOT Position: Q1 2023 in Review

Alpha Wave Global sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 532,570 shares — an estimated $5.38M sold.

Alpha Wave Global first reported a position in BIOT in Q4 2021 and held it in 5 quarters. The position peaked at $5.38M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Alpha Wave Global reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Alpha Wave Global sold 532,570 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $5.38M.
Alpha Wave Global first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2021 and held it in 5 quarters.
Alpha Wave Global's Biotech Acquisition Company Class A Ordinary Shares position peaked at $5.38M in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Alpha Wave Global's 13F filing for Q1 2023, filed 15 May 2023.